Acceptability compliance and adverse reactions when isoniazid, rifampin and pyrazinamide are given as a combined formulation or seperately during three times weekly anti-tuberculosis chemotherapy

Chest Services, Hong Kong and BMRC, London (1989) Acceptability compliance and adverse reactions when isoniazid, rifampin and pyrazinamide are given as a combined formulation or seperately during three times weekly anti-tuberculosis chemotherapy. Ame Rev Resp Dis, 140. 1618.

Full text available as:

HTML
1 Kb

EPrint Type:	Article
Uncontrolled Keywords:	Clinical Trial; SCC; Isoniazid; Rifampin; Pyrazinamide; Hong Kong Chest Service; BMRC
Subjects:	Investigative Techniques > Evaluation Studies > Clinical Trials Therapeutics > Drug Therapy Organic Chemicals > Hydrazines > Isoniazid -Institutional Repositories > National Tuberculosis Institute Geographic Locations > Asia > Far East > China > Hong Kong Heterocyclic Compounds > Heterocyclic Compounds with 4 or More Rings > Rifamycins Respiratory Tract Diseases > Respiratory Tract Infections > Tuberculosis, Pulmonary Pharmaceutical Preparations > Drug Combinations Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Pyrazines
ID Code:	516
Deposited By:	Librarian Sudha S Murthy
Deposited On:	01 August 2005

Archive Staff Only: edit this record